Method for treating gefitinib resistant cancer

Details for Australian Patent Application No. 2006210572 (hide)

Owner The General Hospital Corporation Wyeth

Inventors Godin-Heymann, Nadia G.; Haber, Daniel; Kwak, Eunice L.; Bell, Daphne Winifred; Sordella, Raffaella; Settleman, Jeffrey E.; Rabindran, Sridhar Krishna

Agent Pizzeys

Pub. Number AU-B-2006210572

PCT Pub. Number WO2006/084058

Priority 60/649,483 03.02.05 US; 60/671,989 15.04.05 US

Filing date 2 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 4 August 2011

International Classifications

A61K 31/00 (2006.01)

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084058 Priority application(s): WO2006/084058

23 August 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 23 Jul 2007

4 August 2011 Application Accepted

  Published as AU-B-2006210572

8 September 2011 Alteration of Name

  The name of the applicant has been altered to The General Hospital Corporation; Wyeth LLC 2007

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210587-Aqueous gel formulations containing 1-(2-methylpropyl)-1H-imidazo[4,5-c][1, 5]naphthyridin-4-amine

2006210571-Spinal plating and intervertebral support systems and methods